-
1
-
-
34547927822
-
Invasive aspergillosis: Epidemiology, diagnosis and management in immunocompromised patients
-
Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 2007;67:1567-601.
-
(2007)
Drugs
, vol.67
, pp. 1567-1601
-
-
Maschmeyer, G.1
Haas, A.2
Cornely, O.A.3
-
2
-
-
33750506091
-
Antifungal prophylaxis for invasive mycoses in high risk patients
-
Ullmann AJ, Cornely OA. Antifungal prophylaxis for invasive mycoses in high risk patients. Curr Opin Infect Dis 2006;19:571-6.
-
(2006)
Curr Opin Infect Dis
, vol.19
, pp. 571-576
-
-
Ullmann, A.J.1
Cornely, O.A.2
-
3
-
-
0032886182
-
Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole
-
Glasmacher A, Hahn C, Leutner C, Molitor E, Wardelmann E, Losem C, et al. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses 1999;42:443-51.
-
(1999)
Mycoses
, vol.42
, pp. 443-451
-
-
Glasmacher, A.1
Hahn, C.2
Leutner, C.3
Molitor, E.4
Wardelmann, E.5
Losem, C.6
-
4
-
-
40449105146
-
Reviews of anti-infective agents: Posaconazole: a broad-spectrum triazole antifungal agent
-
Nagappan V, Deresinski S. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin Infect Dis 2007;45:1610-7.
-
(2007)
Clin Infect Dis
, vol.45
, pp. 1610-1617
-
-
Nagappan, V.1
Deresinski, S.2
-
5
-
-
36749026613
-
Posaconazole: An extended-spectrum triazole antifungal agent
-
Schiller DS, Fung HB. Posaconazole: an extended-spectrum triazole antifungal agent. Clin Ther 2007;29:1862-86.
-
(2007)
Clin Ther
, vol.29
, pp. 1862-1886
-
-
Schiller, D.S.1
Fung, H.B.2
-
6
-
-
33846462456
-
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
-
Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348-59.
-
(2007)
N Engl J Med
, vol.356
, pp. 348-359
-
-
Cornely, O.A.1
Maertens, J.2
Winston, D.J.3
Perfect, J.4
Ullmann, A.J.5
Walsh, T.J.6
-
7
-
-
33846410666
-
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
-
Ullmann AJ, Lipton JH, Vesole DH, Chandrasekar P, Langston A, Tarantolo SR, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007;356:335-47.
-
(2007)
N Engl J Med
, vol.356
, pp. 335-347
-
-
Ullmann, A.J.1
Lipton, J.H.2
Vesole, D.H.3
Chandrasekar, P.4
Langston, A.5
Tarantolo, S.R.6
-
8
-
-
1442349141
-
Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men
-
Courtney R, Radwanski E, Lim J, Laughlin M. Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men. Antimicrob Agents Chemother 2004;48:804-8.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 804-808
-
-
Courtney, R.1
Radwanski, E.2
Lim, J.3
Laughlin, M.4
-
9
-
-
1242351713
-
Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults
-
Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 2004;57:218-22.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 218-222
-
-
Courtney, R.1
Wexler, D.2
Radwanski, E.3
Lim, J.4
Laughlin, M.5
-
10
-
-
31944443967
-
Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection
-
Ullmann AJ, Cornely OA, Burchardt A, Hachem R, Kontoyiannis DP, Tö pelt K, et al. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 2006;50:658-66.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 658-666
-
-
Ullmann, A.J.1
Cornely, O.A.2
Burchardt, A.3
Hachem, R.4
Kontoyiannis, D.P.5
Tö pelt, K.6
-
11
-
-
42049108830
-
Therapeutic drug monitoring of anti-fungals: Pharmacokinetic and pharmacodynamic considerations
-
Smith J, Andes D. Therapeutic drug monitoring of anti-fungals: pharmacokinetic and pharmacodynamic considerations. Ther Drug Monit 2008;30:167-72.
-
(2008)
Ther Drug Monit
, vol.30
, pp. 167-172
-
-
Smith, J.1
Andes, D.2
-
12
-
-
34249670227
-
Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection
-
Chhun S, Rey E, Tran A, Lortholary O, Pons G, Jullien V. Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:223-8.
-
(2007)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.852
, pp. 223-228
-
-
Chhun, S.1
Rey, E.2
Tran, A.3
Lortholary, O.4
Pons, G.5
Jullien, V.6
-
13
-
-
43449083749
-
A decade of HPLC-MS/MS in the routine clinical laboratory - goals for further developments
-
Vogeser M, Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory - goals for further developments. Clin Biochem 2008;41:649-62.
-
(2008)
Clin Biochem
, vol.41
, pp. 649-662
-
-
Vogeser, M.1
Seger, C.2
-
14
-
-
0037435949
-
Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the anti-fungal posaconazole in human plasma
-
Kim H, Kumari P, Laughlin M, Hilbert MJ, Indelicato SR, Lim J, et al. Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the anti-fungal posaconazole in human plasma. J Chromatogr A 2003;987:243-8.
-
(2003)
J Chromatogr A
, vol.987
, pp. 243-248
-
-
Kim, H.1
Kumari, P.2
Laughlin, M.3
Hilbert, M.J.4
Indelicato, S.R.5
Lim, J.6
-
15
-
-
33748581308
-
HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases
-
Müller C, Arndt M, Queckenberg C, Cornely OA, Theisohn M. HPLC analysis of the antifungal agent posaconazole in patients with haematological diseases. Mycoses 2006;49(Suppl 1):17-22.
-
(2006)
Mycoses
, vol.49
, Issue.SUPPL. 1
, pp. 17-22
-
-
Müller, C.1
Arndt, M.2
Queckenberg, C.3
Cornely, O.A.4
Theisohn, M.5
-
16
-
-
4344700227
-
Disposition of posaconazole following single-dose oral administration in healthy subjects. Anti-microb
-
Krieter P, Flannery B, Musick T, Gohdes M, Martinho M, Courtney R. Disposition of posaconazole following single-dose oral administration in healthy subjects. Anti-microb Agents Chemother 2004;48:3543-51.
-
(2004)
Agents Chemother
, vol.48
, pp. 3543-3551
-
-
Krieter, P.1
Flannery, B.2
Musick, T.3
Gohdes, M.4
Martinho, M.5
Courtney, R.6
-
17
-
-
33750305753
-
Evaluation of automated micro solid phase extraction tips (micro-SPE) for the validation of a LC-MS/MS bioanalytical method
-
Shen JX, Tama CI, Hayes RN. Evaluation of automated micro solid phase extraction tips (micro-SPE) for the validation of a LC-MS/MS bioanalytical method. J Chromatogr B Analyt Technol Biomed Life Sci 2006;843: 275-82.
-
(2006)
J Chromatogr B Analyt Technol Biomed Life Sci
, vol.843
, pp. 275-282
-
-
Shen, J.X.1
Tama, C.I.2
Hayes, R.N.3
-
18
-
-
33845205158
-
A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma
-
Shen JX, Krishna G, Hayes RN. A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma. J Pharm Biomed Anal 2007;43:228-36.
-
(2007)
J Pharm Biomed Anal
, vol.43
, pp. 228-236
-
-
Shen, J.X.1
Krishna, G.2
Hayes, R.N.3
-
19
-
-
0036188717
-
Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction
-
Vogeser M, Fleischer C, Meiser B, Groetzner J, Spöhrer U, Seidel D. Quantification of sirolimus by liquid chromatography-tandem mass spectrometry using on-line solid-phase extraction. Clin Chem Lab Med 2002;40: 40-5.
-
(2002)
Clin Chem Lab Med
, vol.40
, pp. 40-45
-
-
Vogeser, M.1
Fleischer, C.2
Meiser, B.3
Groetzner, J.4
Spöhrer, U.5
Seidel, D.6
-
20
-
-
0041472496
-
Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction
-
Vogeser M, Spöhrer U, Schiel X. Determination of itraconazole and hydroxyitraconazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin Chem Lab Med 2003; 41:915-20.
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 915-920
-
-
Vogeser, M.1
Spöhrer, U.2
Schiel, X.3
|